Ticker LaunchReverse merger · Completed · CRVO
EIP Pharma, Inc.
Reverse merger with Diffusion Pharmaceuticals Inc. (DFFN)
EIP Pharma, Inc. merged into Diffusion Pharmaceuticals Inc. (DFFN), a Nasdaq-listed clinical-stage biotech pursuing a strategic review, in a reverse merger that takes the private company public. The deal was announced on Mar 30, 2023 and closed on Aug 16, 2023. The combined company trades as CervoMed Inc. (CRVO) on Nasdaq.
CervoMed is a clinical-stage biopharmaceutical company advancing therapeutics for central nervous system and neurodegenerative diseases. Its business comes from EIP Pharma, whose development program centers on the candidate neflamapimod.
- Status
- Completed
- Private company
- EIP Pharma, Inc.
- Public company
- Diffusion Pharmaceuticals Inc. (DFFN)
- Public company business before
- Nasdaq-listed clinical-stage biotech pursuing a strategic review
- Announced
- Mar 30, 2023
- Closed
- Aug 16, 2023
- Combined company
- CervoMed Inc. (CRVO)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- 8-K (merger completion) Aug 17, 2023
- Exhibit 99.1 (completion press release/exhibit)
- All filings on EDGAR CIK 1053691
Other completed reverse mergers
- Dianthus Therapeutics, Inc. (OpCo)into Magenta Therapeutics, Inc. · Sep 11, 2023
- Hong Chang Global Investment Holdings Limited (Hongchang BVI)into Heyu Biological Technology Corporation · Sep 7, 2023
- Dror Ortho-Design Ltd. (Israel)into Novint Technologies, Inc. · Aug 14, 2023
- Serve Robotics Inc.into Patricia Acquisition Corp. · Jul 31, 2023
- Proton Green, LLCinto Cyber App Solutions Corp. · Jul 17, 2023
- Glamourous Groupinto Luduson G Inc. · Jul 6, 2023